【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-06 AccNo: 0001564590-19-029364 Size: 9 MB 网页链接
$Neuronetics(STIM)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-08-06 AccNo: 0001193125-19-214126 Size: 1 MB 网页链接
$Neuronetics(STIM)$ 美东时间 2019-08-06 盘前 披露财报,预期EPS -0.43 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-07-03 AccNo: 0001193125-19-188619 Size: 20 KBItem 7.01: Regulation FD Disclosure 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-07-02 AccNo: 0001193125-19-188335 Size: 145 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial ...
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-05-30 AccNo: 0001193125-19-161336 Size: 39 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements a...
$Neuronetics(STIM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-07 AccNo: 0001564590-19-016516 Size: 7 MB 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-05-07 AccNo: 0001564590-19-016200 Size: 472 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Neuronetics(STIM)$ 美东时间 2019-05-07 盘前 披露财报,预期EPS -0.37 网页链接
$Neuronetics(STIM)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-12 AccNo: 0001193125-19-105287 Size: 401 KB 网页链接